Nerissa T. Viola

This early-phase trial is testing a special PET imaging agent that targets a protein called IFN-gamma to see if it can find lung cancer tumors and show how well they respond to immunotherapy. Six adults with untreated non-small cell lung cancer will get a PET scan before starting…